1.
Testa U, Pelosi E, Castelliu G. Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topic. Ann Ist Super Sanità [Internet]. 2021Dec.10 [cited 2022Jan.26];57(4):300-13. Available from: https://annali.iss.it/index.php/anna/article/view/1386